<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32525788</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>31</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1874-4702</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>5</Issue><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Current molecular pharmacology</Title><ISOAbbreviation>Curr Mol Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Pain Perception and Management: Where do We Stand?</ArticleTitle><Pagination><StartPage>678</StartPage><EndPage>688</EndPage><MedlinePgn>678-688</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2174/1874467213666200611142438</ELocationID><Abstract><AbstractText Label="BACKGROUND">Pain is often flammable, sharp and sometimes described as an electrical shock. It can be categorized in three different ways as nociceptive, neuropathic and inflammatory. Nociceptive pain always originates in specific situations such as in trauma. Neuropathic pain results in nerve damage. In inflammatory pain, inflammatory mediators are involved in the sensitization of nociceptors. It is important to control the pain as it affects the individual physically, mentally, and socially.</AbstractText><AbstractText Label="OBJECTIVE">Recognizing pain physiopathology and pain pathways, defining the relationship between receptor and transmitter is critical in developing new treatment strategies. In this review, current information on the definitions, classifications, and physiological and chemical mechanisms involved in pain are reviewed.</AbstractText><AbstractText Label="METHODS">Various search engines were used to gather related articles/information. Only peer-reviewed journals were considered. Additional, books/chapters of standard publishers were also included in the article.</AbstractText><AbstractText Label="RESULTS">With a better understanding of the physiological and chemical mechanisms that play a role in pain, significant improvements have been made in pain treatment. Various oral or intravenous drugs, local injection treatments, physical and occupational therapy, electrical stimulation, alternative medicine applications, psychological support, and surgical applications are routinely performed in the treatment, dependent upon the type, severity and cause of the pain.</AbstractText><AbstractText Label="CONCLUSION">Improved understanding of pain physiopathology will serve as the basis for future improvements in the delivery of efficacious and reliable treatments, and is likely to rely on novel technological innovations.</AbstractText><CopyrightInformation>Copyright&#xa9; Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Afridi</LastName><ForeName>Bilal</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Abdul Wali Khan University Mardan 23200, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Haroon</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Abdul Wali Khan University Mardan 23200, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akkol</LastName><ForeName>Esra K</ForeName><Initials>EK</Initials><AffiliationInfo><Affiliation>Department of Pharmacognosy, Faculty of Pharmacy, Gazi University 06330, Etiler/Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aschner</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY 10463, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 ES007331</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 ES010563</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United Arab Emirates</Country><MedlineTA>Curr Mol Pharmacol</MedlineTA><NlmUniqueID>101467997</NlmUniqueID><ISSNLinking>1874-4672</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009619" MajorTopicYN="Y">Nociceptors</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010146" MajorTopicYN="Y">Pain</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058748" MajorTopicYN="N">Pain Perception</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Pain pathways</Keyword><Keyword MajorTopicYN="N">available analgesic</Keyword><Keyword MajorTopicYN="N">neurotransmitters</Keyword><Keyword MajorTopicYN="N">nociception</Keyword><Keyword MajorTopicYN="N">pain management</Keyword><Keyword MajorTopicYN="N">pain perception</Keyword><Keyword MajorTopicYN="N">unwanted effects.</Keyword></KeywordList><CoiStatement>CONFLICT OF INTEREST. The authors have no conflicts of interest, financial or otherwise.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>2</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>4</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>12</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32525788</ArticleId><ArticleId IdType="mid">NIHMS1609263</ArticleId><ArticleId IdType="pmc">PMC7728656</ArticleId><ArticleId IdType="doi">10.2174/1874467213666200611142438</ArticleId><ArticleId IdType="pii">CMP-EPUB-107281</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Loeser JD; Treede R-D The Kyoto protocol of IASP Basic Pain Terminology. Pain, 2008, 137(3), 473&#x2013;477. [10.1016/j.pain.2008.04.025]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pain.2008.04.025</ArticleId><ArticleId IdType="pubmed">18583048</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferr&#xe1;ndiz ML; Nacher-Juan J; Alcaraz MJ Nrf2 as a therapeutic target for rheumatic diseases. Biochem. Pharmacol, 2018, 152, 338&#x2013;346. [10.1016/j.bcp.2018.04.010]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2018.04.010</ArticleId><ArticleId IdType="pubmed">29660314</ArticleId></ArticleIdList></Reference><Reference><Citation>Baradaran A; Madihi Y; Merrikhi A; Rafieian-Kopaei M; Nasri H Serum lipoprotein (a) in diabetic patients with various renal function not yet on dialysis.Pak. J. Med. Sci, 2013, 29, 354&#x2013;357. [10.12669/pjms.291(Suppl).3533]</Citation><ArticleIdList><ArticleId IdType="doi">10.12669/pjms.291(Suppl).3533</ArticleId></ArticleIdList></Reference><Reference><Citation>Rafieian-Kopaei M; Ghobadi S; Nasri H The Protective Effect of Garlic Extract on Diabetic Nephropathy. Majallah-i Danishkadah-i Pizishki-i Isfahan, 2013, &#x2022;&#x2022;&#x2022;, 31.</Citation></Reference><Reference><Citation>Khan H Clinical updates on substance-P antagonist in pain management. Biol. Med. (Aligarh), 2014, 6, 4&#x2013;5. [10.4172/0974-8369.1000e113]</Citation><ArticleIdList><ArticleId IdType="doi">10.4172/0974-8369.1000e113</ArticleId></ArticleIdList></Reference><Reference><Citation>McHugh JM; McHugh WB Pain: neuroanatomy, chemical mediators, and clinical implications. AACN Clin. Issues, 2000, 11(2), 168&#x2013;178. [10.1097/00044067-200005000-00003]</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00044067-200005000-00003</ArticleId><ArticleId IdType="pubmed">11235429</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasri H; Rafieian-Kopaei M Protective effects of herbal antioxidants on diabetic kidney disease. J. Res. Med. Sci, 2014, 19(1), 82&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3963332</ArticleId><ArticleId IdType="pubmed">24672573</ArticleId></ArticleIdList></Reference><Reference><Citation>Behradmanesh S; Horestani MK; Baradaran A; Nasri H Association of serum uric acid with proteinuria in type 2 diabetic patients Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences, 2013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3719225</ArticleId><ArticleId IdType="pubmed">23900353</ArticleId></ArticleIdList></Reference><Reference><Citation>Lourdudoss C; Di Giuseppe D; Wolk A; Westerlind H; Klareskog L; Alfredsson L; van Vollenhoven RF; Lampa J Dietary Intake of Polyunsaturated Fatty Acids and Pain in spite of Inflammatory Control among Methotrexate Treated Early Rheumatoid Arthritis Patients. Arthritis Care Res, 2017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5817233</ArticleId><ArticleId IdType="pubmed">28371257</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan H; Pervaiz A; Intagliata S; Das N; Nagulapalli Venkata KC; Atanasov AG; Najda A; Nabavi SM; Wang D; Pittal&#xe0; V; Bishayee A The analgesic potential of glycosides derived from medicinal plants. Daru, 2020, 28(1), 387&#x2013;401. [10.1007/s40199-019-00319-7]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40199-019-00319-7</ArticleId><ArticleId IdType="pmc">PMC7214601</ArticleId><ArticleId IdType="pubmed">32060737</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan H; Saeed M; Gilani A-U-H; Khan MA; Dar A; Khan I The antinociceptive activity of Polygonatum verticillatum rhizomes in pain models.J. Ethnopharmacol, 2010, 127(2), 521&#x2013;527.[10.1016/j.jep.2009.10.003]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2009.10.003</ArticleId><ArticleId IdType="pubmed">19853648</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan MA; Khan H; Khan S; Mahmood T; Khan PM; Jabar A Anti-inflammatory, analgesic and antipyretic activities of Physalis minima Linn.J. Enzyme Inhib. Med. Chem, 2009, 24(3), 632&#x2013;637. [10.1080/14756360802321120]</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14756360802321120</ArticleId><ArticleId IdType="pubmed">18825533</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellerbach J; Schnider O; Besendorf H Synthetic Analgesics: Morphinans: Benzomorphans; Elsevier, 2014.</Citation></Reference><Reference><Citation>Crook J; Rideout E; Browne G The prevalence of pain complaints in a general population. Pain, 1984, 18(3), 299&#x2013;314. [10.1016/0304-3959(84)90824-8]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-3959(84)90824-8</ArticleId><ArticleId IdType="pubmed">6728496</ArticleId></ArticleIdList></Reference><Reference><Citation>Kendig H Health status of older people project: preliminary findings from a survey of the health and lifestyles of older Australians; Victorian Health Promotion Foundation, 1996.</Citation></Reference><Reference><Citation>Barberger-Gateau P; Chaslerie A; Dartigues JF; Commenges D; Gagnon M; Salamon R Health measures correlates in French elderly community population: the PAQUID study. J. Gerontol, 1992, 47(2), S88&#x2013;S95. [10.1093/geronj/47.2.S88]</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronj/47.2.S88</ArticleId><ArticleId IdType="pubmed">1538080</ArticleId></ArticleIdList></Reference><Reference><Citation>Harkins SW Geriatric pain. Pain perceptions in the old. Clin. Geriatr. Med, 1996, 12(3), 435&#x2013;459. [10.1016/S0749-0690(18)30210-6]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0749-0690(18)30210-6</ArticleId><ArticleId IdType="pubmed">8853938</ArticleId></ArticleIdList></Reference><Reference><Citation>Von Korff M; Dworkin SF; Le Resche L Graded chronic pain status: an epidemiologic evaluation. Pain, 1990, 40(3), 279&#x2013;291. [10.1016/0304-3959(90)91125-3]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-3959(90)91125-3</ArticleId><ArticleId IdType="pubmed">2326094</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimby C; Fastbom J; Forsell Y; Thorslund M; Claesson CB; Winblad B Musculoskeletal pain and analgesic therapy in a very old population. Arch. Gerontol. Geriatr, 1999, 29(1), 29&#x2013;43. [10.1016/S0167-4943(99)00021-7]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0167-4943(99)00021-7</ArticleId><ArticleId IdType="pubmed">15374075</ArticleId></ArticleIdList></Reference><Reference><Citation>Helme RD; Gibson SJ Pain in older people Epidemiology of pain, 1999, 103&#x2013;112.</Citation></Reference><Reference><Citation>Andersson HI; Ejlertsson G; Leden I; Rosenberg C Chronic pain in a geographically defined general population: studies of differences in age, gender, social class, and pain localization. Clin. J. Pain, 1993, 9(3), 174&#x2013;182. [10.1097/00002508-199309000-00004]</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00002508-199309000-00004</ArticleId><ArticleId IdType="pubmed">8219517</ArticleId></ArticleIdList></Reference><Reference><Citation>Leveille SG; Guralnik JM; Ferrucci L; Hirsch R; Simon-sick E; Hochberg MC Foot pain and disability in older women. Am. J. Epidemiol, 1998, 148(7), 657&#x2013;665. [10.1093/aje/148.7.657]</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/148.7.657</ArticleId><ArticleId IdType="pubmed">9778172</ArticleId></ArticleIdList></Reference><Reference><Citation>Mobily PR; Herr KA; Clark MK; Wallace RB An epidemiologic analysis of pain in the elderly: The Iowa 65+ Rural Health Study. J. Aging Health, 1994, 6, 139&#x2013;154. [10.1177/089826439400600201]</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/089826439400600201</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook NR; Evans DA; Funkenstein HH; Scherr PA; Ostfeld AM; Taylor JO; Hennekens CH Correlates of headache in a population-based cohort of elderly.Arch. Neurol, 1989, 46(12), 1338&#x2013;1344. [10.1001/archneur.1989.00520480082024]</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1989.00520480082024</ArticleId><ArticleId IdType="pubmed">2590019</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Alessandro R; Benassi G; Lenzi PL; Gamberini G; Sacquegna T; De Carolis P; Lugaresi E Epidemiology of headache in the Republic of San Marino. J. Neurol. Neurosurg. Psychiatry, 1988, 51(1), 21&#x2013;27. [10.1136/jnnp.51.1.21]</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.51.1.21</ArticleId><ArticleId IdType="pmc">PMC1032709</ArticleId><ArticleId IdType="pubmed">3258357</ArticleId></ArticleIdList></Reference><Reference><Citation>Kay L; J&#xf8;rgensen T; Schultz-Larsen K Abdominal pain in a 70-year-old Danish population. An epidemiological study of the prevalence and importance of abdominal pain. J. Clin. Epidemiol, 1992, 45(12), 1377&#x2013;1382. [10.1016/0895-4356(92)90199-W]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0895-4356(92)90199-W</ArticleId><ArticleId IdType="pubmed">1460475</ArticleId></ArticleIdList></Reference><Reference><Citation>Sternbach RA Survey of pain in the United States: the Nuprin pain report. Clin. J. Pain, 1986, 2, 49&#x2013;53. [10.1097/00002508-198602010-00008]</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00002508-198602010-00008</ArticleId><ArticleId IdType="pubmed">3785965</ArticleId></ArticleIdList></Reference><Reference><Citation>Magni G; Rossi MR; Rigatti-Luchini S; Merskey H Chronic abdominal pain and depression. Epidemiologic findings in the United States. Hispanic Health and Nutrition Examination Survey. Pain, 1992, 49(1), 77&#x2013;85. [10.1016/0304-3959(92)90191-D]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-3959(92)90191-D</ArticleId><ArticleId IdType="pubmed">1594284</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoller EP; Forster LE; Portugal S Self-care responses to symptoms by older people. A health diary study of illness behavior. Med. Care, 1993, 31(1), 24&#x2013;42. [10.1097/00005650-199301000-00002]</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005650-199301000-00002</ArticleId><ArticleId IdType="pubmed">8417268</ArticleId></ArticleIdList></Reference><Reference><Citation>Tibblin G; Bengtsson C; Furunes B; Lapidus L Symptoms by age and sex. The population studies of men and women in Gothenburg, Sweden. Scand. J. Prim. Health Care, 1990, 8(1), 9&#x2013;17. [10.3109/02813439008994923]</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/02813439008994923</ArticleId><ArticleId IdType="pubmed">2356375</ArticleId></ArticleIdList></Reference><Reference><Citation>Harkins SW; Chapman CR Detection and decision factors in pain perception in young and elderly men. Pain, 1976, 2(3), 253&#x2013;264. [10.1016/0304-3959(76)90004-X]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-3959(76)90004-X</ArticleId><ArticleId IdType="pubmed">1026903</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavsky-Shulan M; Wallace RB; Kohout FJ; Lemke JH; Morris MC; Smith IM Prevalence and functional correlates of low back pain in the elderly: the Iowa 65+ Rural Health Study. J. Am. Geriatr. Soc, 1985, 33(1), 23&#x2013;28. [10.1111/j.1532-5415.1985.tb02855.x]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.1985.tb02855.x</ArticleId><ArticleId IdType="pubmed">3155530</ArticleId></ArticleIdList></Reference><Reference><Citation>Loney PL; Stratford PW The prevalence of low back pain in adults: a methodological review of the literature.Phys. Ther, 1999, 79(4), 384&#x2013;396. [10.1093/ptj/79.4.384]</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ptj/79.4.384</ArticleId><ArticleId IdType="pubmed">10201544</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassols A; Bosch F; Campillo M; Ca&#xf1;ellas M; Ba&#xf1;os J -E. An epidemiological comparison of pain complaints in the general population of Catalonia (Spain). Pain, 1999, 83(1), 9&#x2013;16. [10.1016/S0304-3959(99)00069-X]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0304-3959(99)00069-X</ArticleId><ArticleId IdType="pubmed">10506667</ArticleId></ArticleIdList></Reference><Reference><Citation>Brattberg G; Thorslund M; Wikman A The prevalence of pain in a general population. The results of a postal survey in a county of Sweden. Pain, 1989, 37(2), 215&#x2013;222. [10.1016/0304-3959(89)90133-4]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-3959(89)90133-4</ArticleId><ArticleId IdType="pubmed">2748195</ArticleId></ArticleIdList></Reference><Reference><Citation>Von Korff M; Dworkin SF; Le Resche L; Kruger A An epidemiologic comparison of pain complaints. Pain, 1988, 32(2), 173&#x2013;183. [10.1016/0304-3959(88)90066-8]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-3959(88)90066-8</ArticleId><ArticleId IdType="pubmed">3362555</ArticleId></ArticleIdList></Reference><Reference><Citation>Brattberg G; Parker MG; Thorslund M The prevalence of pain among the oldest old in Sweden. Pain, 1996, 67(1), 29&#x2013;34. [10.1016/0304-3959(96)03047-3]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-3959(96)03047-3</ArticleId><ArticleId IdType="pubmed">8895228</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrar JT; Young JP, Jr; LaMoreaux, L.; Werth, J.L.; Poole, R.M. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain, 2001, 94(2), 149&#x2013;158. [10.1016/S0304-3959(01)00349-9]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0304-3959(01)00349-9</ArticleId><ArticleId IdType="pubmed">11690728</ArticleId></ArticleIdList></Reference><Reference><Citation>Huguet A; Mir&#xf3; J The severity of chronic pediatric pain: an epidemiological study. J. Pain, 2008, 9(3), 226&#x2013;236. [10.1016/j.jpain.2007.10.015]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpain.2007.10.015</ArticleId><ArticleId IdType="pubmed">18088558</ArticleId></ArticleIdList></Reference><Reference><Citation>Cousins MJ Persistent pain: a disease entity. J. Pain Symptom Manage, 2007, 33, S4&#x2013;S10. [10.1016/j.jpainsymman.2006.09.007]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpainsymman.2006.09.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Miranda C; Di Virgilio M; Selleri S; Zanotti G; Pagliardini S; Pierotti MA; Greco A Novel pathogenic mechanisms of congenital insensitivity to pain with anhidrosis genetic disorder unveiled by functional analysis of neurotrophic tyrosine receptor kinase type 1/nerve growth factor receptor mutations. J. Biol. Chem, 2002, 277(8), 6455&#x2013;6462. [10.1074/jbc.M110016200]</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110016200</ArticleId><ArticleId IdType="pubmed">11719521</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang SS; Chang VT; Kasimis B Cancer breakthrough pain characteristics and responses to treatment at a VA medical center. Pain, 2003, 101(1&#x2013;2), 55&#x2013;64. [10.1016/S0304-3959(02)00293-2]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0304-3959(02)00293-2</ArticleId><ArticleId IdType="pubmed">12507700</ArticleId></ArticleIdList></Reference><Reference><Citation>Crepax P; Silvestrini B Experimental evaluation in laboratory animals of anti-inflammatory analgesic drugs. Arch. Ital. Biol, 1963, 101, 444&#x2013;457.</Citation><ArticleIdList><ArticleId IdType="pubmed">14163909</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinegar R; Truax JF; Selph JL Quantitative comparison of the analgesic and anti-inflammatory activities of aspirin, phenacetin and acetaminophen in rodents. Eur. J. Pharmacol, 1976, 37(1), 23&#x2013;30. [10.1016/0014-2999(76)90004-2]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-2999(76)90004-2</ArticleId><ArticleId IdType="pubmed">1278245</ArticleId></ArticleIdList></Reference><Reference><Citation>Winder CV; Wax J; Burr V; Been M; Rosiere CE A study of pharmacological influences on ultraviolet erythema in guinea pigs. Arch. Int. Pharmacodyn. Ther, 1958, 116(3&#x2013;4), 261&#x2013;293.</Citation><ArticleIdList><ArticleId IdType="pubmed">13584058</ArticleId></ArticleIdList></Reference><Reference><Citation>Hebbes C Non-opioid analgesics. Anaesth. Intensive Care Med, 2016, 17, 469&#x2013;472. [10.1016/j.mpaic.2016.06.013]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mpaic.2016.06.013</ArticleId></ArticleIdList></Reference><Reference><Citation>Franklin KB; Abbott FV Techniques for assessing the effects of drugs on nociceptive responses.Psychopharmacology; Springer, 1989, pp. 145&#x2013;216. [10.1385/0-89603-129-2:145]</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/0-89603-129-2:145</ArticleId></ArticleIdList></Reference><Reference><Citation>Rice AS; Farquhar-Smith WP; Bridges D; Brooks JW Cannabinoids and pain. Prog. Pain Res. Manag, 2003, 24, 437&#x2013;468.</Citation></Reference><Reference><Citation>Stein C; Machelska H; Binder W; Sch&#xe4;fer M Peripheral opioid analgesia. Curr. Opin. Pharmacol, 2001, 1(1), 62&#x2013;65. [10.1016/S1471-4892(01)00005-4]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1471-4892(01)00005-4</ArticleId><ArticleId IdType="pubmed">11712537</ArticleId></ArticleIdList></Reference><Reference><Citation>Boddeke EW Involvement of chemokines in pain. Eur. J. Pharmacol, 2001, 429(1&#x2013;3), 115&#x2013;119. [10.1016/S0014-2999(01)01311-5]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0014-2999(01)01311-5</ArticleId><ArticleId IdType="pubmed">11698032</ArticleId></ArticleIdList></Reference><Reference><Citation>Verkhratsky A; Kettenmann H Calcium signalling in glial cells. Trends Neurosci, 1996, 19(8), 346&#x2013;352. [10.1016/0166-2236(96)10048-5]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0166-2236(96)10048-5</ArticleId><ArticleId IdType="pubmed">8843604</ArticleId></ArticleIdList></Reference><Reference><Citation>Park EH; Lee SW; Moon SW; Suh HR; Kim YI; Han HC Activation of peripheral group III metabotropic glutamate receptors inhibits pain transmission by decreasing neuronal excitability in the CFA-inflamed knee joint.Neurosci. Lett, 2019, 694, 111&#x2013;115. [10.1016/j.neulet.2018.11.033]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2018.11.033</ArticleId><ArticleId IdType="pubmed">30472359</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo H; Liu H-Z; Zhang W-W; Matsuda M; Lv N; Chen G; Xu Z-Z; Zhang Y-Q Interleukin-17 Regulates Neuron-Glial Communications, Synaptic Transmission, and Neuropathic Pain after Chemotherapy. Cell Rep, 2019, 29(8), 2384&#x2013;2397.e5. [10.1016/j.celrep.2019.10.085]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.10.085</ArticleId><ArticleId IdType="pubmed">31747607</ArticleId></ArticleIdList></Reference><Reference><Citation>Cayre M; Buckingham SD; Yagodin S; Sattelle DB Cultured insect mushroom body neurons express functional receptors for acetylcholine, GABA, glutamate, octopamine, and dopamine.J. Neurophysiol, 1999, 81(1), 1&#x2013;14. [10.1152/jn.1999.81.1.1]</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.1999.81.1.1</ArticleId><ArticleId IdType="pubmed">9914262</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge M-M; Chen S-P; Zhou Y-Q; Li Z; Tian X-B; Gao F; Manyande A; Tian Y-K; Yang H The therapeutic potential of GABA in neuron-glia interactions of cancer-induced bone pain. Eur. J. Pharmacol, 2019, 858172475 [10.1016/j.ejphar.2019.172475.]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2019.172475</ArticleId><ArticleId IdType="pubmed">31228456</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe T; Matsumura S; Katano T; Mabuchi T; Takagi K; Xu L; Yamamoto A; Hattori K; Yagi T; Watanabe M; Nakazawa T; Yamamoto T; Mishina M; Nakai Y; Ito S Fyn kinase--mediated phosphorylation of NMDA receptor NR2B subunit at Tyr1472 is essential for maintenance of neuropathic pain. Eur. J. Neurosci, 2005, 22(6), 1445&#x2013;1454. [10.1111/j.1460-9568.2005.04340.x]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2005.04340.x</ArticleId><ArticleId IdType="pubmed">16190898</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisenach JC; Detweiler DJ; Tong C; D&#x2019;Angelo R; Hood DD Cerebrospinal fluid norepinephrine and acetylcholine concentrations during acute pain. Anesth. Analg, 1996, 82(3), 621&#x2013;626. [10.1213/00000539-199603000-00034]</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/00000539-199603000-00034</ArticleId><ArticleId IdType="pubmed">8623972</ArticleId></ArticleIdList></Reference><Reference><Citation>Puopolo M The hypothalamic-spinal dopaminergic system: a target for pain modulation. Neural Regen. Res, 2019, 14(6), 925&#x2013;930.[10.4103/1673-5374.250567]</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.250567</ArticleId><ArticleId IdType="pmc">PMC6404492</ArticleId><ArticleId IdType="pubmed">30761995</ArticleId></ArticleIdList></Reference><Reference><Citation>Villemure C; Bushnell MC Cognitive modulation of pain: how do attention and emotion influence pain processing? Pain, 2002, 95(3), 195&#x2013;199. [10.1016/S0304-3959(02)00007-6]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0304-3959(02)00007-6</ArticleId><ArticleId IdType="pubmed">11839418</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagelberg N; J&#xe4;&#xe4;skel&#xe4;inen SK; Martikainen IK; Mansikka H; Forssell H; Scheinin H; Hietala J; Pertovaara A Striatal dopamine D2 receptors in modulation of pain in humans: a review. Eur. J. Pharmacol, 2004, 500(1&#x2013;3), 187&#x2013;192. [10.1016/j.ejphar.2004.07.024]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2004.07.024</ArticleId><ArticleId IdType="pubmed">15464032</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala I; Martos NF; Silvan G; Gutierrez-Panizo C; Clavel JG; Illera JC Cortisol, adrenocorticotropic hormone, serotonin, adrenaline and noradrenaline serum concentrations in relation to disease and stress in the horse. Res. Vet. Sci, 2012, 93(1), 103&#x2013;107.[10.1016/j.rvsc.2011.05.013]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rvsc.2011.05.013</ArticleId><ArticleId IdType="pubmed">21641009</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimura M; Furue H Mechanisms for the anti-nociceptive actions of the descending noradrenergic and serotonergic systems in the spinal cord. J. Pharmacol. Sci, 2006, 101(2), 107&#x2013;117. [10.1254/jphs.CRJ06008X]</Citation><ArticleIdList><ArticleId IdType="doi">10.1254/jphs.CRJ06008X</ArticleId><ArticleId IdType="pubmed">16766858</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao Y-X; Gu J; Stephens RL Jr Role of spinal cord glutamate transporter during normal sensory transmission and pathological pain states. Mol. Pain, 2005, 1, 30. [10.1186/1744-8069-1-30]</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1744-8069-1-30</ArticleId><ArticleId IdType="pmc">PMC1274343</ArticleId><ArticleId IdType="pubmed">16242033</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallbo AB; Johansson RS Properties of cutaneous mechanoreceptors in the human hand related to touch sensation. Hum. Neurobiol, 1984, 3(1), 3&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">6330008</ArticleId></ArticleIdList></Reference><Reference><Citation>Woolf CJ; Benos DJ; Abboud F; Koopman W; Epstein P American College of Physicians; American Physiological Society. Pain: moving from symptom control toward mechanism-specific pharmacologic management. Ann. Intern. Med, 2004, 140(6), 441&#x2013;451. [10.7326/0003-4819-140-8-200404200-00010]</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-140-8-200404200-00010</ArticleId><ArticleId IdType="pubmed">15023710</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald J; Lambert D Opioid receptors. Contin. Educ. Anaesth. Crit. Care Pain, 2005, 5, 22&#x2013;25. [10.1093/bjaceaccp/mki004]</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bjaceaccp/mki004</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilbert JA; Richelson E Function of delta opioid receptors in cultured cells. Mol. Cell. Biochem, 1983, 55(1), 83&#x2013;19. [10.1007/BF00229244]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00229244</ArticleId><ArticleId IdType="pubmed">6137764</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein C; Millan MJ; Shippenberg TS; Peter K; Herz A Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors. J. Pharmacol. Exp. Ther, 1989, 248(3), 1269&#x2013;1275.</Citation><ArticleIdList><ArticleId IdType="pubmed">2539460</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubieta J-K; Smith YR; Bueller JA; Xu Y; Kilbourn MR; Jewett DM; Meyer CR; Koeppe RA; Stohler CS Regional mu opioid receptor regulation of sensory and affective dimensions of pain science, 2001, 293, 311&#x2013;315.</Citation><ArticleIdList><ArticleId IdType="pubmed">11452128</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohn LM; Gainetdinov RR; Lin F-T; Lefkowitz RJ; Caron MG &#x3bc;-opioid receptor desensitization by &#x3b2;-arrestin-2 determines morphine tolerance but not dependence. Nature, 2000, 408(6813), 720&#x2013;723.[10.1038/35047086]</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35047086</ArticleId><ArticleId IdType="pubmed">11130073</ArticleId></ArticleIdList></Reference><Reference><Citation>Michel ME; Bolger G; Weissman BA Binding of a new opiate antagonist, nalmefene, to rat brain membranes. Methods Find. Exp. Clin. Pharmacol, 1985, 7(4), 175&#x2013;177.</Citation><ArticleIdList><ArticleId IdType="pubmed">2991678</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman E; Jin L-Q; Cai G-P; Hollon TR; Drago J; Sibley DR; Wang H-Y D1-like dopaminergic activation of phosphoinositide hydrolysis is independent of D1A dopamine receptors: evidence from D1A knockout mice.Mol. Pharmacol, 1997, 51(1), 6&#x2013;11.[10.1124/mol.51.1.6]</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/mol.51.1.6</ArticleId><ArticleId IdType="pubmed">9016340</ArticleId></ArticleIdList></Reference><Reference><Citation>Montezinho LP; M&#xf8;rk A; Duarte CB; Penschuck S; Geraldes CF; Castro MMC Effects of mood stabilizers on the inhibition of adenylate cyclase via dopamine D(2)-like receptors. Bipolar Disord., 2007, 9(3), 290&#x2013;297. [10.1111/j.1399-5618.2007.00354.x]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-5618.2007.00354.x</ArticleId><ArticleId IdType="pubmed">17430304</ArticleId></ArticleIdList></Reference><Reference><Citation>Momiyama T; Koga E Dopamine D(2)-like receptors selectively block N-type Ca(2+) channels to reduce GABA release onto rat striatal cholinergic interneurones.J. Physiol, 2001, 533(Pt 2), 479&#x2013;492. [10.1111/j.1469-7793.2001.0479a.x]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-7793.2001.0479a.x</ArticleId><ArticleId IdType="pmc">PMC2278623</ArticleId><ArticleId IdType="pubmed">11389206</ArticleId></ArticleIdList></Reference><Reference><Citation>Paus S; Brecht HM; K&#xf6;ster J; Seeger G; Klockgether T; W&#xfc;llner U Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson&#x2019;s disease. Mov. Disord, 2003, 18(6), 659&#x2013;667. [10.1002/mds.10417]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.10417</ArticleId><ArticleId IdType="pubmed">12784269</ArticleId></ArticleIdList></Reference><Reference><Citation>Berthelsen S; Pettinger WA A functional basis for classification of &#x3b1;-adrenergic receptors. Life Sci, 1977, 21(5), 595&#x2013;606. [10.1016/0024-3205(77)90066-2]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0024-3205(77)90066-2</ArticleId><ArticleId IdType="pubmed">20542</ArticleId></ArticleIdList></Reference><Reference><Citation>Bylund DB Subtypes of alpha 1- and alpha 2-adrenergic receptors. FASEB J, 1992, 6(3), 832&#x2013;839. [10.1096/fasebj.6.3.1346768]</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fasebj.6.3.1346768</ArticleId><ArticleId IdType="pubmed">1346768</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronica SM; Kraus WL; Katzenellenbogen BS Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc. Natl. Acad. Sci. USA, 1994, 91(18), 8517&#x2013;8521. [10.1073/pnas.91.18.8517]</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.91.18.8517</ArticleId><ArticleId IdType="pmc">PMC44637</ArticleId><ArticleId IdType="pubmed">8078914</ArticleId></ArticleIdList></Reference><Reference><Citation>Ossipov MH; Dussor GO; Porreca F Central modulation of pain. J. Clin. Invest, 2010, 120(11), 3779&#x2013;3787. [10.1172/JCI43766]</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI43766</ArticleId><ArticleId IdType="pmc">PMC2964993</ArticleId><ArticleId IdType="pubmed">21041960</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Byrne PM; Israel E; Drazen JM Antileukotrienes in the treatment of asthma. Ann. Intern. Med, 1997, 127(6), 472&#x2013;480. [10.7326/0003-4819-127-6-199709150-00009]</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-127-6-199709150-00009</ArticleId><ArticleId IdType="pubmed">9313005</ArticleId></ArticleIdList></Reference><Reference><Citation>Detsi A; Majdalani M; Kontogiorgis CA; Hadjipavlou-Litina D; Kefalas P Natural and synthetic 2&#x2032;-hydroxy-chalcones and aurones: synthesis, characterization and evaluation of the antioxidant and soybean lipoxygenase inhibitory activity. Bioorg. Med. Chem, 2009, 17(23), 8073&#x2013;8085. [10.1016/j.bmc.2009.10.002]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2009.10.002</ArticleId><ArticleId IdType="pubmed">19853459</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan H; Saeed M; Muhammad N; Gaffar R; Gul F; Raziq N Lipoxygenase and urease inhibition of the aerial parts of the Polygonatum verticillatum. Toxicol. Ind. Health, 2015, 31(8), 758&#x2013;763. [10.1177/0748233713483197]</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0748233713483197</ArticleId><ArticleId IdType="pubmed">23552263</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan H; Saeed M; Khan MA; Muhammad N; Khan A; Ullah A Lipoxygenase and Urease Inhibition of extracts of Polygonatum verticillatum Rhizome: Augmented by its isolated compound, santonin. J. Chem. Soc. Pak, 2014, 36, 865&#x2013;869.</Citation></Reference><Reference><Citation>Khan I; Nisar M; Ebad F; Nadeem S; Saeed M; Khan H; Samiullah; Khuda, F.; Karim, N.; Ahmad, Z. Anti-inflammatory activities of Sieboldogenin from Smilax china Linn.: experimental and computational studies.J. Ethnopharmacol, 2009, 121(1), 175&#x2013;177.[10.1016/j.jep.2008.10.009]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2008.10.009</ArticleId><ArticleId IdType="pubmed">19007873</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan I; Nisar M; Shah MR; Shah H; Gilani SN; Gul F; Abdullah SM; Ismail M; Khan N; Kaleem WA; Qayum M; Khan H; Obaidullah; Samiullah; Ullah M Anti-inflammatory activities of Taxusabietane A isolated from Taxus wallichiana Zucc. Fitoterapia, 2011, 82(7), 1003&#x2013;1007. [10.1016/j.fitote.2011.06.003]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fitote.2011.06.003</ArticleId><ArticleId IdType="pubmed">21699963</ArticleId></ArticleIdList></Reference><Reference><Citation>Calder PC n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am. J. Clin. Nutr, 2006, 83(6)(Suppl.), 1505S&#x2013;1519S.[10.1093/ajcn/83.6.1505S]</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/83.6.1505S</ArticleId><ArticleId IdType="pubmed">16841861</ArticleId></ArticleIdList></Reference><Reference><Citation>Garavito RM; DeWitt DL The cyclooxygenase isoforms: structural insights into the conversion of arachidonic acid to prostaglandins. Biochim. Biophys. Acta, 1999, 1441(2&#x2013;3), 278&#x2013;287. [10.1016/S1388-1981(99)00147-X]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1388-1981(99)00147-X</ArticleId><ArticleId IdType="pubmed">10570255</ArticleId></ArticleIdList></Reference><Reference><Citation>Tatsuguchi A; Sakamoto C; Wada K; Akamatsu T; Tsukui T; Miyake K; Futagami S; Kishida T; Fukuda Y; Yamanaka N; Kobayashi M Localisation of cyclooxygenase 1 and cyclooxygenase 2 in Helicobacter pylori related gastritis and gastric ulcer tissues in humans. Gut, 2000, 46(6), 782&#x2013;789. [10.1136/gut.46.6.782]</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.46.6.782</ArticleId><ArticleId IdType="pmc">PMC1756437</ArticleId><ArticleId IdType="pubmed">10807888</ArticleId></ArticleIdList></Reference><Reference><Citation>Willoughby DA; Moore AR; Colville-Nash PR COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease. Lancet, 2000, 355(9204), 646&#x2013;648. [10.1016/S0140-6736(99)12031-2]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(99)12031-2</ArticleId><ArticleId IdType="pubmed">10696997</ArticleId></ArticleIdList></Reference><Reference><Citation>Fr&#xf6;lich JC A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes.Trends Pharmacol. Sci, 1997, 18(1), 30&#x2013;34. [10.1016/S0165-6147(96)01017-6]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-6147(96)01017-6</ArticleId><ArticleId IdType="pubmed">9114728</ArticleId></ArticleIdList></Reference><Reference><Citation>Rainsford KD Profile and mechanisms of gastrointestinal and other side effects of nonsteroidal anti-inflammatory drugs (NSAIDs). Am. J. Med, 1999, 107(6A), 27S&#x2013;35S. [10.1016/S0002-9343(99)00365-4]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9343(99)00365-4</ArticleId><ArticleId IdType="pubmed">10628591</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones CA; Voaklander DC; Johnston DWC; Suarez-Almazor ME The effect of age on pain, function, and quality of life after total hip and knee arthroplasty.Arch. Intern. Med, 2001, 161(3), 454&#x2013;460. [10.1001/archinte.161.3.454]</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.161.3.454</ArticleId><ArticleId IdType="pubmed">11176772</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine FM; De Simone LL The effects of experimenter gender on pain report in male and female subjects. Pain, 1991, 44(1), 69&#x2013;72. [10.1016/0304-3959(91)90149-R]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-3959(91)90149-R</ArticleId><ArticleId IdType="pubmed">2038491</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvillo ER; Flaskerud JH Review of literature on culture and pain of adults with focus on Mexican-Americans.J. Transcult. Nurs, 1991, 2(2), 16&#x2013;23. [10.1177/104365969100200203]</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/104365969100200203</ArticleId><ArticleId IdType="pubmed">2043291</ArticleId></ArticleIdList></Reference><Reference><Citation>Bantick SJ; Wise RG; Ploghaus A; Clare S; Smith SM; Tracey I Imaging how attention modulates pain in humans using functional MRI. Brain, 2002, 125(Pt 2), 310&#x2013;319. [10.1093/brain/awf022]</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awf022</ArticleId><ArticleId IdType="pubmed">11844731</ArticleId></ArticleIdList></Reference><Reference><Citation>Irwin MR; Olmstead R; Carrillo C; Sadeghi N; Fitzgerald JD; Ranganath VK; Nicassio PM Sleep loss exacerbates fatigue, depression, and pain in rheumatoid arthritis. Sleep (Basel), 2012, 35(4), 537&#x2013;543. [10.5665/sleep.1742]</Citation><ArticleIdList><ArticleId IdType="doi">10.5665/sleep.1742</ArticleId><ArticleId IdType="pmc">PMC3296796</ArticleId><ArticleId IdType="pubmed">22467992</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen MP; Chen C; Brugger AM Postsurgical pain outcome assessment. Pain, 2002, 99(1&#x2013;2), 101&#x2013;109. [10.1016/S0304-3959(02)00063-5]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0304-3959(02)00063-5</ArticleId><ArticleId IdType="pubmed">12237188</ArticleId></ArticleIdList></Reference><Reference><Citation>Boivie J; Hansson P; Lindblom U Touch, temperature, and pain in health and disease: mechanisms and assessments: a Wenner-Gren Center International Symposium IASP press1994.</Citation></Reference><Reference><Citation>Turk DC; Melzack R The measurement of pain and the assessment of people experiencing pain, 2001.</Citation></Reference><Reference><Citation>Britain RPSoG. British National Formulary 58; Royal Pharmaceutical Society, 2009.</Citation></Reference><Reference><Citation>N&#xe4;rv&#xe4;nen T; Halsas M; Smal J; Marvola M Is one paraceta molsuppository of 1000 mg bioequivalent with two suppositories of 500 mg. Eur. J. Drug Metab. Pharmacokinet, 1998, 23(2), 203&#x2013;206.[10.1007/BF03189340]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03189340</ArticleId><ArticleId IdType="pubmed">9725482</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf8;ller PL; N&#xf8;rholt SE; Ganry HE; Insuasty JH; Vincent FG; Skoglund LA; Sindet-Pedersen S Time to onset of analgesia and analgesic efficacy of effervescent acetaminophen 1000 mg compared to tablet acetaminophen 1000 mg in postoperative dental pain: a single-dose, double-blind, randomized, placebo-controlled study. J. Clin. Pharmacol, 2000, 40(4), 370&#x2013;378. [10.1177/00912700022009071]</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00912700022009071</ArticleId><ArticleId IdType="pubmed">10761164</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolin SJ; Cashman JN; Bland JM Effectiveness of acute postoperative pain management: I. Evidence from published data. Br.J. Anaesth, 2002, 89(3), 409&#x2013;423. [10.1093/bja/89.3.409]</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/89.3.409</ArticleId><ArticleId IdType="pubmed">12402719</ArticleId></ArticleIdList></Reference><Reference><Citation>Usach I; Martinez R; Festini T; Peris J-E Subcutaneous Injection of Drugs: Literature Review of Factors Influencing Pain Sensation at the Injection Site. Adv. Ther, 2019, 36(11), 2986&#x2013;2996. [10.1007/s12325-019-01101-6]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12325-019-01101-6</ArticleId><ArticleId IdType="pmc">PMC6822791</ArticleId><ArticleId IdType="pubmed">31587143</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore RA; Tram&#xe8;r MR; Carroll D; Wiffen PJ; McQuay HJ Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs. BMJ, 1998, 316(7128), 333&#x2013;338. [10.1136/bmj.316.7128.333]</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.316.7128.333</ArticleId><ArticleId IdType="pmc">PMC2665568</ArticleId><ArticleId IdType="pubmed">9487165</ArticleId></ArticleIdList></Reference><Reference><Citation>Ansel H; Allen L Jr; Popovich N Modified release dosage forms and drug delivery systems. Pharmaceutical Dosage Forms and Drug Delivery Systems, 1999, 7, 229&#x2013;243.</Citation></Reference><Reference><Citation>Zhang H; Zhang J; Streisand JB Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications. Clin. Pharmacokinet, 2002, 41(9), 661&#x2013;680. [10.2165/00003088-200241090-00003]</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00003088-200241090-00003</ArticleId><ArticleId IdType="pubmed">12126458</ArticleId></ArticleIdList></Reference><Reference><Citation>Alves RR; Rosa IL; Santana GG The role of animal-derived remedies as complementary medicine in Brazil. Bioscience, 2007, 57, 949&#x2013;955.[10.1641/B571107]</Citation><ArticleIdList><ArticleId IdType="doi">10.1641/B571107</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilson AM; Ryan KM; Joranson DE; Dahl JL A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997&#x2013;2002. J. Pain Symptom Manage, 2004, 28(2), 176&#x2013;188. [10.1016/j.jpainsymman.2004.01.003]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpainsymman.2004.01.003</ArticleId><ArticleId IdType="pubmed">15276196</ArticleId></ArticleIdList></Reference><Reference><Citation>Conaghan PG A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity. Rheumatol. Int, 2012, 32(6), 1491&#x2013;1502. [10.1007/s00296-011-2263-6]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-011-2263-6</ArticleId><ArticleId IdType="pmc">PMC3364420</ArticleId><ArticleId IdType="pubmed">22193214</ArticleId></ArticleIdList></Reference><Reference><Citation>Compton WM; Volkow ND Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend, 2006, 81(2), 103&#x2013;107. [10.1016/j.drugalcdep.2005.05.009]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drugalcdep.2005.05.009</ArticleId><ArticleId IdType="pubmed">16023304</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xfc;rsteler-MacFarland KM; Fischer DA; Mueller S; Schmid O; Moldovanyi A; Wiesbeck GA Symptom complaints of patients prescribed either oral methadone or injectable heroin.J. Subst. Abuse Treat, 2010, 38(4), 328&#x2013;337. [10.1016/j.jsat.2010.01.008]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsat.2010.01.008</ArticleId><ArticleId IdType="pubmed">20206457</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes PJ; Adcock I; Spedding M; Vanhoutte PM Anti-inflammatory actions of steroids: molecular mechanisms.Trends Pharmacol. Sci, 1993, 14(12), 436&#x2013;441. [10.1016/0165-6147(93)90184-L]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-6147(93)90184-L</ArticleId><ArticleId IdType="pubmed">7510080</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MH Pharmacologic treatment of cancer pain. N. Engl. J. Med, 1996, 335(15), 1124&#x2013;1132. [10.1056/NEJM199610103351507]</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199610103351507</ArticleId><ArticleId IdType="pubmed">8813044</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xe4;cke H; D&#xf6;cke W-D; Asadullah K Mechanisms involved in the side effects of glucocorticoids.Pharmacol. Ther, 2002, 96(1), 23&#x2013;43. [10.1016/S0163-7258(02)00297-8]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0163-7258(02)00297-8</ArticleId><ArticleId IdType="pubmed">12441176</ArticleId></ArticleIdList></Reference><Reference><Citation>Wade JB; Dougherty LM; Hart RP; Cook DB Patterns of normal personality structure among chronic pain patients.Pain,1992, 48(1), 37&#x2013;43. [10.1016/0304-3959(92)90129-Y]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-3959(92)90129-Y</ArticleId><ArticleId IdType="pubmed">1738573</ArticleId></ArticleIdList></Reference><Reference><Citation>Uzun S; Kozumplik O; Jakovljevi&#x107; M; Sedi&#x107; B Side effects of treatment with benzodiazepines. Psychiatr. Danub, 2010, 22(1), 90&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">20305598</ArticleId></ArticleIdList></Reference><Reference><Citation>Lands WE Actions of anti-inflammatory drugs. Trends Pharmacol. Sci, 1981, 2, 78&#x2013;80. [10.1016/0165-6147(81)90270-4]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-6147(81)90270-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinhilber D 5-Lipoxygenase: a target for antiinflammatory drugs revisited. Curr. Med. Chem, 1999, 6(1), 71&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">9873115</ArticleId></ArticleIdList></Reference><Reference><Citation>Nie D; Honn KV Cyclooxygenase, lipoxygenase and tumor angiogenesis. Cell. Mol. Life Sci, 2002, 59(5), 799&#x2013;807. [10.1007/s00018-002-8468-9]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-002-8468-9</ArticleId><ArticleId IdType="pmc">PMC11146107</ArticleId><ArticleId IdType="pubmed">12088280</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>